AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,002.00p
   
  • Change Today:
      33.00p
  • 52 Week High: 13,276.00p
  • 52 Week Low: 9,501.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.30m
  • Volume: 1,083,409
  • Market Cap: £155,061m
  • RiskGrade: 123
  • Beta: 0.87

Latest ShareCast News

AstraZeneca's Tagrisso recommended for EU approval

By Iain Gilbert

Date: Monday 18 Nov 2024

(Sharecast News) - Drugmaker AstraZeneca said on Monday that its Tagrisso asset had received a recommendation for EU approval on the back of LAURA Phase III trial results, which revealed it had extended median progression-free survival to more than three years.

AstraZeneca ShareCast News

Sunday newspaper round-up: Kursk, AstraZeneca, B... 17-Nov-2024 ShareCast
London close: Stocks end turbulent week in the red 15-Nov-2024 ShareCast
Director dealings: AstraZeneca CEO ups stake 15-Nov-2024 ShareCast
London close: Stocks sink as UK jobless rate rises 12-Nov-2024 ShareCast
AstraZeneca upgrades full-year guidance amid str... 12-Nov-2024 ShareCast

AstraZeneca Regulatory News

Director/PDMR Shareholding 20-Nov-2024 16:00 RNS
Tagrisso recommended for EU approval - LAURA 18-Nov-2024 07:00 RNS
Director/PDMR Shareholding 15-Nov-2024 14:00 RNS
Director/PDMR Shareholding 15-Nov-2024 10:00 RNS
Director/PDMR Shareholding 13-Nov-2024 16:00 RNS

AstraZeneca Newspaper Links

AstraZeneca boss says staff in China breached ru... 13-Nov-2024 Times
AstraZeneca raises forecasts amid investigations... 12-Nov-2024 Times
Fighting Frenchman shows us how as he ensures As... 30-Dec-2014 Daily Mail
Exclusive: UK firms vie for share of £170bn in A... 08-Dec-2014 The Independent
MARKET REPORT: Ariad on the up amid growing spec... 04-Dec-2014 Daily Mail

AstraZeneca Tips & Analysis

Questor :AstraZeneca 29-Apr-2014 Telegraph
Questor : AstraZeneca 24-Jan-2014 Telegraph
Questor:AstraZeneca 22-Dec-2011 Telegraph
Investment Column:AstraZeneca 28-Oct-2011 The Independent
Investment Column: AstraZeneca 23-Jun-2011 The Independent

AstraZeneca News Wires

MedImmune Announces Zook as President 13-Nov-2008 PR Newswire
Survey Shows Lung Cancer Patients Blamed for The... 12-Nov-2008 PR Newswire
CRESTOR Demonstrates Dramatic CV Risk Reduction ... 09-Nov-2008 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,002.00p
Change Today 33.00p
% Change 0.33 %
52 Week High 13,276.00p
52 Week Low 9,501.00p
Volume 1,083,409
Shares Issued 1,550.30m
Market Cap £155,061m
Beta 0.87
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
87.66% below the market average87.66% below the market average87.66% below the market average87.66% below the market average87.66% below the market average
88% below the sector average88% below the sector average88% below the sector average88% below the sector average88% below the sector average
Price Trend
27.11% below the market average27.11% below the market average27.11% below the market average27.11% below the market average27.11% below the market average
34.69% above the sector average34.69% above the sector average34.69% above the sector average34.69% above the sector average34.69% above the sector average
Income
78.05% below the market average78.05% below the market average78.05% below the market average78.05% below the market average78.05% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Growth
88.44% above the market average88.44% above the market average88.44% above the market average88.44% above the market average88.44% above the market average
94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average

What The Brokers Say

Strong Buy 9
Buy 15
Neutral 5
Sell 0
Strong Sell 1
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 08-Aug-24 22-Feb-24
Paid 09-Sep-24 25-Mar-24
Amount 100.00¢ 197.00¢

Trades for 21-Nov-2024

Time Volume / Share Price
13:11 70 @ 10,002.00p
13:11 126 @ 10,002.00p
13:11 32 @ 10,004.00p
13:11 178 @ 10,002.00p
13:11 42 @ 10,002.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page